Out-of-Favor Drugs Stocks May be the Right Medicine For Your Portfolio [Forbes]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Forbes
Out-of-Favor Drugs Stocks May be the Right Medicine For Your Portfolio Drug stocks have been out of favor due to regulatory concerns and pricing pressure that will add headline risk throughout the election cycle. Nevertheless, several top-tier stock experts and contributors to Show.com see select opportunities for long-term value investors to consider buying large cap pharmaceutical names. Joe Duarte In the Options Pharmaceutical stocks have been beyond wallflowers in 2019. In fact, some of them, like drug giant Pfizer Still, if you look at stock charts, it’s hard to ignore that money has been moving into the shares of late; and perhaps with good reason. That’s because deep inside the archives of Pfizer’s drug portfolio is a new medication called Vyndagel, which treats a frequently undiagnosed form of congestive heart failure known as ATTR. Without getting into the medical weeds, just know that ATTR is a condition in which a protein builds up in the heart muscle resulting in the stif
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock [Yahoo! Finance]Yahoo! Finance
- Pfizer On The New Lows List. Big Dividend Fails To Attract Buyers. [Forbes]Forbes
- Automation in Biopharma Industry market is projected to grow at a CAGR of 7% by 2034: Visiongain [Yahoo! Finance]Yahoo! Finance
- Ewing Sarcoma Drug Pipeline Market Research 2024: Insights About 25+ Companies and 25+ Pipeline Drugs [Yahoo! Finance]Yahoo! Finance
- Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth [Seeking Alpha]Seeking Alpha
PFE
Earnings
- 1/30/24 - Beat
PFE
Sec Filings
- 4/16/24 - Form 4
- 4/16/24 - Form 4
- 4/16/24 - Form PX14A6G
- PFE's page on the SEC website